Study identifies common mechanism behind widespread cancer mutations
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine investigators.
Read original article on The Medical News →Related news
-
New microscopy platform enables imaging of neuronal activity at single-cell resolution at unprecedented tissue depth
United Kingdom
-
Living near water-pollution sources associated with rare brain disorder
United Kingdom
-
UCSF scientists develop smart CAR-T cells to fight childhood brain tumors
United Kingdom
-
Tiny corneal bumps reveal potential path toward treating severe vision loss
United Kingdom
-
Study shows income gaps drive disparities in universal healthcare access
United Kingdom
-
Inflammatory macrophages identified as drivers of chronic joint osteoarthritis
United Kingdom
-
Researchers identify protein that drives chronic inflammation in psoriasis
United Kingdom
-
Human challenge study reveals how preexisting immunity affects dengue
United Kingdom